Five Prime Therapeutics

2y ago, source: PMLiVE

This page shows the latest Five Prime Therapeutics news and features for those working in and with pharma, biotech and healthcare. Five Prime's pipeline includes potentially first-in-class anti-FGFR2b ...

PFIZER INC's Net Worth

2mon ago, source: Benzinga.com

Flexion Therapeutics Inc, Celladon Corp, Zoetis Inc., ICAGEN INC, ENCYSIVE PHARMACEUTICALS INC, ARQULE INC, FIVE PRIME THERAPEUTICS INC, KING PHARMACEUTICALS INC, Coley Pharmaceutical Group ...

FHTX Foghorn Therapeutics Inc.

5d ago, source: Seeking Alpha

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin ...

Design Therapeutics Inc DSGN

5d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

DMAC DiaMedica Therapeutics Inc.

5d ago, source: Seeking Alpha

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead ...

Astria Therapeutics, Inc. (ATXS)

5d ago, source: Yahoo Finance

BOSTON, April 09, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced ...

Viking Therapeutics Inc VKTX

11d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Revance Therapeutics, Inc. (RVNC)

6d ago, source: Yahoo Finance

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript February 29, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Spero Therapeutics Inc.

6d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Which Is a Better Investment, Celldex Therapeutics, Inc. or BIO-TECHNE Corp Stock?

5d ago, source: American Association of Individual Investors

Learn more about whether Celldex Therapeutics, Inc. or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor ...

Nurix Therapeutics (NRIX) Price Target Increased by 5.58% to 25.09

7d ago, source: Hosted on MSN

The average one-year price target for Nurix Therapeutics (NasdaqGM:NRIX) has been revised to 25.09 / share. This is an ...

Which Is a Better Investment, Janux Therapeutics Inc or BIO-TECHNE Corp Stock?

5d ago, source: American Association of Individual Investors

Learn more about whether Janux Therapeutics Inc or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor grades, ...